tiprankstipranks
GeneOne Life Science, Inc. (KR:011000)
:011000
South Korea Market
011000
GeneOne Life Science, Inc.
RESEARCH TOOLSreports

GeneOne Life Science, Inc. (011000) Financial Statements

― Followers

GeneOne Life Science, Inc. Financial Overview

GeneOne Life Science, Inc.'s market cap is currently ₩48.51B. The company's EPS TTM is ₩-11847.9; its P/E ratio is -0.23; GeneOne Life Science, Inc. is scheduled to report earnings on August 14, 2026, and the estimated EPS forecast is ₩―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue₩ 23.93B₩ 35.72B₩ 40.20B₩ 48.72B₩ 38.70B
Gross Profit₩ -21.43B₩ -10.87B₩ -7.76B₩ 9.34B₩ 8.76B
Operating Income₩ -42.42B₩ -43.04B₩ -48.37B₩ -40.08B₩ -27.51B
EBITDA₩ -28.60B₩ -28.64B₩ -63.70B₩ -25.32B₩ -6.54B
Net Income₩ -47.66B₩ -48.54B₩ -77.77B₩ -38.15B₩ -15.95B
Balance Sheet
Cash & Short-Term Investments₩ 3.21B₩ 1.75B₩ 9.99B₩ 45.60B₩ 107.40B
Total Assets₩ 119.21B₩ 151.33B₩ 151.01B₩ 222.87B₩ 249.50B
Total Debt₩ 32.96B₩ 27.13B₩ 17.16B₩ 19.67B₩ 18.40B
Net Debt₩ 31.62B₩ 25.95B₩ 8.05B₩ 6.40B₩ -3.91B
Total Liabilities₩ 78.31B₩ 65.73B₩ 39.52B₩ 41.40B₩ 44.04B
Stockholders' Equity₩ 40.90B₩ 85.61B₩ 111.49B₩ 181.47B₩ 206.51B
Cash Flow
Free Cash Flow₩ -16.55B₩ -19.42B₩ -27.40B₩ -69.52B₩ -87.37B
Operating Cash Flow₩ -16.52B₩ -16.06B₩ -21.74B₩ -24.11B₩ -4.85B
Investing Cash Flow₩ -769.89M₩ -2.85B₩ 25.89B₩ 8.06B₩ -146.40B
Financing Cash Flow₩ 17.45B₩ 10.96B₩ -8.29B₩ 7.01B₩ 111.02B
Currency in KRW

GeneOne Life Science, Inc. Earnings and Revenue History

Income Statement >

GeneOne Life Science, Inc. Debt to Assets

Balance Sheet >

GeneOne Life Science, Inc. Cash Flow

Cash Flow >

GeneOne Life Science, Inc. Forecast EPS vs Actual EPS

Earnings >